Flaxseed enhances the beneficial effect of low-dose estrogen therapy at reducing bone turnover and preserving bone microarchitecture in ovariectomized rats

Applied Physiology, Nutrition and Metabolism

Volumn 39, Issue 7, 2014, Pages 801-810

  Sacco, Sandra M ^a   Chen, Jianmin ^a   Ganss, Bernhard ^a   Thompson, Lilian U ^a   Ward, Wendy E ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b BROCK UNIVERSITY   (Canada)

Author keywords

Bone histology; Bone microarchitecture; Bone turnover; Flaxseed; Low dose estrogen therapy; Lumbar vertebra; Ovariectomized rats

Indexed keywords

ESTRADIOL; ESTROGEN;

ANATOMY AND HISTOLOGY; ANIMAL; BONE; BONE REMODELING; DRUG EFFECTS; ESTROGEN THERAPY; FEMALE; FLAX; OVARIECTOMY; PHYSIOLOGY; RANDOMIZATION; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; BONE AND BONES; BONE REMODELING; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; FLAX; OVARIECTOMY; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84903445796     PISSN: 17155312     EISSN: 17155320     Source Type: Journal    
DOI: 10.1139/apnm-2013-0417     Document Type: Article

References (55)

1. Abdelkarem, H.M., Abd El-Kader, M.M., and Kasem, S.A. 2011. Manipulation of flaxseed inhibits tumor necrosis factor-alpha and interleukin-6 production in ovarian-induced osteoporosis. Saudi Med. J. 32(4): 369-375. PMID: 21483995.
2. Allred, D.C., Harvey, J.M., Berardo, M., and Clark, G.M. 1998. Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod. Pathol. 11(2): 155-168. PMID:9504686.
3. Babu, U.S., Mitchell, G.V., Wiesenfeld, P., Jenkins, M.Y., and Gowda, H. 2000. Nutritional and hematological impact of dietary flaxseed and defatted flaxseed meal in rats. Int. J. Food Sci. Nutr. 51(2): 109-117. doi:10.1080/ 096374800100804. PMID:10953754.
4. Boyce, B.F., and Xing, L. 2007. Biology of RANK, RANKL, and osteoprotegerin. Arthritis Res. Ther. 9(Suppl. 1): S1. doi:10.1186/ar2165. PMID:17634140.
5. Brooks, J.D., Ward, W.E., Lewis, J.E., Hilditch, J., Nickell, L., Wong, E., and Thompson, L.U. 2004. Supplementation with flaxseed alters estrogen metabolism in postmenopausal women to a greater extent than does supplementation with an equal amount of soy. Am. J. Clin. Nutr. 79(2): 318-325. PMID: 14749240.
6. Canadian Council on Animal Care. 1993. Guide to the Care and Use of Experimental Animals. Canadian Council on Animal Care. Edited by ErnestD.Olfert, Brenda M. Cross, and A. Ann McWilliam. Available from http://www.ccac.ca/Documents/Standards/Guidelines/Experimental_Animals_Vol1.pdf. [Accessed 15 August 2013.]
7. Casado-Diaz, A., Santiago-Mora, R., Dorado, G., and Quesada-Gomez, J.M. 2013. The omega-6 arachidonic fatty acid, but not the omega-3 fatty acids, inhibits osteoblastogenesis and induces adipogenesis of human mesenchymal stem cells: potential implication in osteoporosis. Osteoporos. Int. 24(5): 1647-1661. doi:10.1007/s00198-012-2138-z. PMID:23104199.
8. Casari, E., Alfano, M., Valente, M., Clarke, G.D., Ferni, G., and Grazioli, B. 1997. Ovariectomy in the rat induces a rapid increase in the urinary excretion of hydroxylysine glycosides and non-reducible crosslink residues. Osteoporos. Int. 7(6): 539-543. doi:10.1007/BF02652559. PMID:9604049.
9. Chen, J., Power, K.A., Mann, J., Cheng, A., and Thompson, L.U. 2007. Flaxseed alone or in combination with tamoxifen inhibits MCF-7 breast tumor growth in ovariectomized athymic mice with high circulating levels of estrogen. Exp. Biol. Med. (Maywood), 232(8): 1071-1080. doi:10.3181/0702-RM-36. PMID: 17720953.
10. Cohen, S.L., Moore, A.M., and Ward, W.E. 2005. Flaxseed oil and inflammation-associated bone abnormalities in interleukin-10 knockout mice. J. Nutr. Biochem. 16(6): 368-374. doi:10.1016/j.jnutbio.2005.01.008. PMID:15936649.
11. Delmas, P.D., Marianowski, L., Perez Ade, C., Ribot, C., Pornel, B., Palacios, S., and Lopes, P. 2004. Prevention of postmenopausal bone loss by pulsed estrogen therapy: comparison with transdermal route. Maturitas, 48(2): 85-96. doi:10.1016/j.maturitas.2004.01.012. PMID:15172082.
12. Dodin, S., Lemay, A., Jacques, H., Légaré, F., Forest, J.C., and Mâsse, B. 2005. The effects of flaxseed dietary supplement on lipid profile, bone mineral density, and symptoms in menopausal women: a randomized, double-blind, wheat germ placebo-controlled clinical trial. J. Clin. Endocrinol. Metab. 90(3): 1390-1397. doi:10.1210/jc.2004-1148. PMID:15613422.
13. Dupasquier, C.M., Dibrov, E., Kneesh, A.L., Cheung, P.K., Lee, K.G., Alexander, H.K., et al. 2007. Dietary flaxseed inhibits atherosclerosis in the LDL receptor-deficient mouse in part through antiproliferative and anti-inflammatory actions. Am. J. Physiol. Heart Circ. Physiol. 293(4): H2394-H2402. doi:10.1152/ajpheart.01104.2006. PMID:17616740.
14. Farmer, C., Petit, H.V., Weiler, H., and Capuco, A.V. 2007. Effects of dietary supplementation with flax during prepuberty on fatty acid profile, mammo-genesis, and bone resorption in gilts. J. Anim. Sci. 85(7): 1675-1686. doi:10. 2527/jas.2007-0022. PMID:17400971.
15. Gopala Krishnan, V., Arunakaran, J., Govindarajulu, P., and Srinivasan, N. 2003. Effects of estradiol and progesterone on vertebral collagen, glycosami-noglycans and phosphatases in ovariectomized adult rats. Horm. Metab. Res. 35(3): 137-141. doi:10.1055/s-2003-39073. PMID:12734772.
16. Griel, A.E., Kris-Etherton, P.M., Hilpert, K.F., Zhao, G., West, S.G., and Corwin, R.L. 2007. An increase in dietary n-3 fatty acids decreases a marker of bone resorption in humans. Nutr. J. 6(2): 1-8. doi:10.1186/1475-2891-6-2. PMID: 17227589.
17. Hersh, A.L., Stefanick, M.L., and Stafford, R.S. 2004. National use of postmeno-pausal hormone therapy: annual trends and response to recent evidence. JAMA, 291(1): 47-53. doi:10.1001/jama.291.1.47. PMID:14709575.
18. Horwood, N.J., Elliott, J., Martin, T.J., and Gillespie, M.T. 1998. Osteotropic agents regulate the expression of osteoclast differentiation factor and osteoprote-gerin in osteoblastic stromal cells. Endocrinology, 139(11): 4743-4746. doi:10. 1210/endo.139.11.6433. PMID:9794488.
19. Huang, A.J., Ettinger, B., Vittinghoff, E., Ensrud, K.E., Johnson, K.C., and Cummings, S.R. 2007. Endogenous estrogen levels and the effects of ultra-low-dose transdermal estradiol therapy on bone turnover and BMD in post-menopausal women. J. Bone Miner. Res. 22(11): 1791-1797. doi:10.1359/jbmr. 070707. PMID:17620054.
20. Hutchins, A.M., Brown, B.D., Cunnane, S.C., Domitrovich, S.G., Adams, E.R., and Bobowiec, C.E. 2013. Daily flaxseed consumption improves glycemic control in obese men and women with pre-diabetes: a randomized study. Nutr. Res. 33(5): 367-375. doi:10.1016/j.nutres.2013.02.012. PMID:23684438.
21. Jiang, J.M., Sacco, S.M., and Ward, W.E. 2008. Ovariectomy-induced hyperphagia does not modulate bone mineral density or bone strength in rats. J. Nutr. 138(11): 2106-2110. doi:10.3945/jn.108.093781. PMID:18936205.
22. Khosla, S. 2001. Minireview: the OPG/RANKL/RANK system. Endocrinology, 142(12): 5050-5055. doi:10.1210/endo.142.12.8536. PMID:11713196.
23. Laux, M. 2012. Flax Profile. Agricultural Marketing Resource Center. Available from http://www.agmrc.org/commodities_products/grains_oilseeds/flax-profile/. [Accessed 19 August 2013.]
24. Leibbrandt, A., and Penninger, J.M. 2008. RANK/RANKL: regulators of immune responses and bone physiology. Ann. N.Y. Acad. Sci. 1143: 123-150. doi:10. 1196/annals.1443.016. PMID:19076348.
25. Lindahl, G., Saarinen, N., Abrahamsson, A., and Dabrosin, C. 2011. Tamoxifen, flaxseed, and the lignan enterolactone increase stroma- and cancer cell-derived IL-1Ra and decrease tumor angiogenesis in estrogen-dependent breast cancer. Cancer Res. 71(1): 51-60. doi:10.1158/0008-5472.CAN-10-2289. PMID:21097717.
26. Lowcock, E.C., Cotterchio, M., and Boucher, B.A. 2013. Consumption of flaxseed, a rich source of lignans, is associated with reduced breast cancer risk. Cancer Causes Control, 24(4): 813-816. doi:10.1007/s10552-013-0155-7. PMID:23354422.
27. Lucas, E.A., Wild, R.D., Hammond, L.J., Khalil, D.A., Juma, S., Daggy, B.P., et al. 2002. Flaxseed improves lipid profile without altering biomarkers of bone metabolism in postmenopausal women. J. Clin. Endocrinol. Metab. 87(4): 1527-1532. doi:10.1210/jcem.87.4.8374. PMID:11932276.
28. Lukas, R., Gigliotti, J.C., Smith, B.J., Altman, S., and Tou, J.C. 2011. Consumption of different sources of omega-3 polyunsaturated fatty acids by growing female rats affects long bone mass and microarchitecture. Bone, 49(3): 455-462. doi:10.1016/j.bone.2011.05.029. PMID:21672645.
29. Mahady, G.B., Parrot, J., Lee, C., Yun, G.S., and Dan, A. 2003. Botanical dietary supplement use in peri- and postmenopausal women. Menopause, 10(1): 65-72. doi:10.1097/00042192-200310010-00011. PMID:12544679.
30. Mukherjee, M., Das, A.S., Das, D., Mukherjee, S., Mitra, S., and Mitra, C. 2006. Effects of garlic oil on postmenopausal osteoporosis using ovariectomized rats: comparison with the effects of lovastatin and 17beta-estradiol. Phyto-ther. Res. 20(1): 21-27. doi:10.1002/ptr.1795. PMID:16397916.
31. Nakamura, M.T., Cho, H.P., Xu, J., Tang, Z., and Clarke, S.D. 2001. Metabolism and functions of highly unsaturated fatty acids: an update. Lipids, 36(9): 961-964. doi:10.1007/s11745-001-0806-5. PMID:11724468.
32. Nakashima, K., Zhou, X., Kunkel, G., Zhang, Z., Deng, J.M., Behringer, R.R., and de Crombrugghe, B. 2002. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell, 108(1): 17-29. doi:10.1016/S0092-8674(01)00622-5. PMID:11792318.
33. Nguyen-Yamamoto, L., Bolivar, I., Strugnell, S.A., and Goltzman, D. 2010. Comparison of active vitamin D compounds and a calcimimetic in mineral ho-meostasis.J.Am. Soc. Nephrol. 21(10): 1713-1723. doi:10.1681/ASN.2009050531. PMID:20651168.
34. NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy. 2001. Osteoporosis Prevention, Diagnosis, and Therapy. JAMA, 285: 785-795. doi:10.1001/jama.285.6.785. PMID:11176917.
35. North American Menopause Society. 2012. Hormone Products for Postmeno-pausal use in the United States and Canada. Available from http://www.menopause.org/htcharts.pdf. [Accessed 16 December 2013.]
36. Osteoporosis Canada. 2013. Osteoporosis at-a-glance. Available from http://www.osteoporosis.ca/osteoporosis-and-you/. [Accessed 16 December 2013.]
37. Pan, A., Yu, D., Demark-Wahnefried, W., Franco, O.H., and Lin, X. 2009. Meta-analysis of the effects of flaxseed interventions on blood lipids. Am. J. Clin. Nutr. 90(2): 288-297. doi:10.3945/ajcn.2009.27469. PMID:19515737.
38. Penttinen, P., Jaehrling, J., Damdimopoulos, A.E., Inzunza, J., Lemmen, J.G., van der Saag, P., et al. 2007. Diet-derived polyphenol metabolite enterolac-tone is a tissue-specific estrogen receptor activator. Endocrinology, 148(10): 4875-4886. doi:10.1210/en.2007-0289. PMID:17628008.
39. Penttinen-Damdimopoulou, P.E., Power, K.A., Hurmerinta, T.T., Nurmi, T., van der Saag, P.T., and Mäkelä, S.I. 2009. Dietary sources of lignans and isoflavones modulate responses to estradiol in estrogen reporter mice. Mol. Nutr. Food Res. 53(8): 996-1006. doi:10.1002/mnfr.200800487. PMID: 19603405.
40. Peris, P., Alvarez, L., Monegal, A., Guañabens, N., Durán, M., Pons, F., et al. 1999. Biochemical markers of bone turnover after surgical menopause and hormone replacement therapy. Bone, 25(3): 349-353. doi:10.1016/S8756-3282 (99)00175-1. PMID:10495139.
41. Poulsen, R.C., Moughan, P.J., and Kruger, M.C. 2008. Docosahexaenoic acid and 17 beta-estradiol co-treatment is more effective than 17 beta-estradiol alone in maintaining bone post-ovariectomy. Exp. Biol. Med. (Maywood), 233(5): 592-602. doi:10.3181/0709-RM-259. PMID:18375826.
42. Rahman, M.M., Bhattacharya, A., Banu, J., Kang, J.X., and Fernandes, G. 2009. Endogenous n-3 fatty acids protect ovariectomy induced bone loss by attenuating osteoclastogenesis. J. Cell. Mol. Med. 13(8B): 1833-1844. doi:10.1111/j. 1582-4934.2008.00649.x. PMID:20141608.
43. Reeves, P.G. 1997. Components of the AIN-93 diets as improvements in the AIN-76A diet. J. Nutr. 127(5): S838-S841. PMID:9164249.
44. Sacco, S.M., and Ward, W.E. 2010. Revisiting estrogen: efficacy and safety for postmenopausal bone health. J. Osteoporos. 708931. doi:10.4061/2010/708931. PMID:20981150.
45. Sacco, S.M., Jiang, J.M., Reza-Lopez, S., Ma, D.W., Thompson, L.U., and Ward, W.E. 2009. Flaxseed combined with low-dose estrogen therapy preserves bone tissue in ovariectomized rats. Menopause, 16(3): 545-554. doi:10. 1097/gme.0b013e31818fc00a. PMID:19182694.
46. Schlemmer, C.K., Coetzer, H., Claassen, N., and Kruger, M.C. 1999. Oestrogen and essential fatty acid supplementation corrects bone loss due toovariectomy in the female Sprague Dawley rat. Prostaglandins Leukot. Essent. Fatty Acids, 61(6): 381-390. doi:10.1054/plef.1999.0116. PMID:10718112.
47. Seibel, M.J. 2000. Molecular markers of bone turnover: biochemical, technical and analytical aspects. Osteoporos. Int. 11(Suppl. 6): S18-S29. doi:10.1007/s001980070003. PMID:11193236.
48. Singh, S.R., and Levine, M.A. 2006. Natural health product use in Canada: analysis of the National Population Health Survey. Can. J. Clin. Pharmacol. 13(2): e240-e250. PMID:16921199.
49. Thompson, D.D., Simmons, H.A., Pirie, C.M., and Ke, H.Z. 1995. FDA Guidelines and animal models for osteoporosis. Bone, 17(4 Suppl.): 125S-133S. doi:10. 1016/8756-3282(95)00285-L. PMID:8579908.
50. Thompson, L.U., Chen, J.M., Li, T., Strasser-Weippl, K., and Goss, P.E. 2005. Dietary flaxseed alters tumor biological markers in postmenopausal breast cancer. Clin. Cancer Res. 11(10): 3828-3835. doi:10.1158/1078-0432.CCR-04-2326. PMID:15897583.
51. Ward, W.E., and Thompson, L.U. 2013. Flaxseed and bone health in animal models of menopause. In Nutrition and Diet in Menopause. Edited by C.J. Hollins Martin, R.R. Watson, and V.R. Preedy. Humana Press, London, UK. pp. 419-426. doi:10.1007/978-1-62703-373-2_31.
52. Ward, W.E., Yuan, Y.V., Cheung, A.M., and Thompson, L.U. 2001. Exposure to purified lignan from flaxseed (Linum usitatissimum) alters bone development in female rats. Br. J. Nutr. 86(4): 499-505. doi:10.1079/BJN2001429. PMID: 11591237.
53. Ward, W.E., Yuan, Y.V., Cheung, A.M., and Thompson, L.U. 2001. Exposure to flaxseed and its purified lignan reduces bone strength in young but not older male rats. J. Toxicol. Environ. Health A, 63(1): 53-65. doi:10.1080/ 152873901750128362. PMID:11346133.
54. Wronski, T.J., Cintron, M., and Dann, L.M. 1988. Temporal relationship between bone loss and increased bone turnover in ovariectomized rats. Calcif. Tissue Int. 43(3): 179-183. doi:10.1007/BF02571317. PMID:3141020.
55. Zhang, Y., Lai, W.P., Leung, P.C., Wu, C.F., and Wong, M.S. 2007. Short- to midterm effects of ovariectomy on bone turnover, bone mass and bone strength in rats. Biol. Pharm. Bull. 30(5): 898-903. doi:10.1248/bpb.30.898. PMID: 17473432.